Life Science Medical Communications Conference

Day One Agenda
Tuesday, February 11

8:00   REGISTRATION & WELCOME COFFEE

8:50   CHAIRPERSON’S OPENING REMARKS
Ed Shifflett, EVP Strategic Account Development
RED NUCLEUS

9:00   KEYNOTE PANEL: 2025 INDUSTRY OUTLOOK ON THE EVOLUTION OF THE MEDICAL COMMUNICATION LANDSCAPE
• Continued increase in popularity and dependence of AI technology
• Top priority components when developing a robust scientific platform
• Examination of considerations when drawing upon patients as authors
• Generating and leveraging improved feedback data from publications
Susan Malecha, GILEAD SCIENCES
Jennifer Totten, MIRUM PHARMACEUTICALS
Poonam Bordoloi, JOHNSON & JOHNSON
Paul O’Grady, BRISTOL MYERS SQUIBB

9:45   CASE STUDY: APPLICATION OF AI AS A WRITING TOOL ENSURING CONSISTENCY AND
QUALITY
• Softwares available with AI inclusions for writing assistance
• Rigorous review processes of AI produced deliverables
• Tailoring AI prompts according to desired output results
Matthew Lewis, Co-Founder and Board Member
FOUNDATION FOR AI & HEALTH

10:30   COFFEE & NETWORKING BREAK

11:00   CASE STUDY: INCREASING ACCEPTANCE AND UTILIZATION OF ADVANCING AI
TECHNOLOGY
• Methods to promote quick implementation of AI innovations
• Continual education in line with emerging advancements
• Frameworks for strengthening trust in utilization of AI
• Communicating importance of cross-functional adoption
Kate Dryga, Sr. Manager, Medical Information
CHIESI GLOBAL RARE DISEASES

11:45   SMALL GROUP DISCUSSION: CONSIDERATIONS OF AI TECHNOLOGY APPLICABILITY
With the consideration of the increasing popularity and continued evolution of AI
technology within medical communications, it is important to consider potential use
cases and how applying AI to various tasks will affect both industry output and
employees utilizing the technology. This interactive discussion will break audience
members into self-determined groups to discuss scenarios in which AI should or should
not be applied to in order to establish these appropriate use guidelines compliantly and
ethically.
Matthew Lewis, Co-Founder and Board Member
FOUNDATION FOR AI & HEALTH

12:30   LUNCHEON FOR ALL SPEAKERS, SPONSORS & ATTENDEES

1:30   LEGAL PERSPECTIVE: LATEST AI REGULATORY AND COMPLIANCE RESTRICTIONS
• Current realities of use limitations when employing AI
• Appropriate verbiage surrounding AI use in publications
• Maintaining legal compliance when implementing AI
Kevin Coy, Partner and Privacy Group Co-Chair
ARNALL GOLDEN GREGORY LLP

2:15   PANEL DISCUSSION: STRATEGIES FOR INTERNAL ADAPTABILITY AND CHANGE MANAGEMENT
• Preserving a stable work environment amid company reorganizations
• Trainings and education for building upon change management skills
• Goal alignment for maintaining confidence and trust among employees
Moderator:
Susan Malecha, GILEAD SCIENCES
Panelists:
Priya Londhe, GILEAD SCIENCES
Preeti Sule, MODERNA
Paul O’Grady, BRISTOL MYERS SQUIBB

3:00   COFFEE & NETWORKING BREAK

3:30   CASE STUDY: CROSS-FUNCTIONAL COLLABORATION IN DEVELOPING SCIENTIFIC PLATFORMS
• Foresight for initiating cross-functionality in early phase development
• Aligning scientific platform goals in line with organization-wide objectives
• Identifying potential compliance barriers for cross-functional collaboration
Preeti Sule, Director, Scientific Communications – Respiratory Vaccines
MODERNA

4:15  CASE STUDY: FRAMEWORKS FOR ENSURING TIMELY UPDATES OF SCIENTIFIC PLATFORMS
• Anticipating, planning, and prioritizing relevant updates
• Assigning task responsibilities according to required updates
• Exploring alternative formats to improve utility of platforms and efficiency of updates
• Ensuring appropriate review and impactful roll-out of updates
Jennifer Totten, Senior Director Medical Affairs
MIRUM PHARMACEUTICALS

5:00   Closing Remarks & End of Day 1

Day Two Agenda
Wednesday, February 12

8:30   REGISTRATION & WELCOME COFFEE

8:50   CHAIRPERSON’S OPENING REMARKS

9:00   PANEL DISCUSSION: PERSPECTIVES ON EMPLOYING PATIENTS AS AUTHORS FOR PUBLICATIONS
• Distinctions between patient perspective inclusion and patient authors
• Balancing patient author involvement and professional expert opinions
• Impact of patients as authors incorporation on prospective payers
Moderator:
Dikran Toroser, NOVARTIS (contract)
Panelists:
Laura Dormer, JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH

9:45   CASE STUDY: FACTORS TO CONSIDER WHEN DECIDING BETWEEN IN-HOUSE AND
OUTSOURCING OF WRITING REVIEWS
• Identifying bandwidth availability of teams for comprehensive reviews
• Determining priority deliverables to ensure thorough in-house evaluation
• Potential benefits of utilizing AI to retain in-house review processes
• Importance of outside perspectives to reduce bias in deliverables
Debra Mayo, Executive Director Global Medical Communications & Operations
OTSUKA

10:30   COFFEE & NETWORKING BREAK

11:00   CASE STUDY: NAVIGATING DIVERSE MESSAGING STYLES WHEN WRITING FOR HCPs
With rising expectations regarding the alignment of content deliverables to the target
audience, challenges arise in identifying the most effective writing style for each
audience to ensure the intended messaging is accurately conveyed. This session will
provide the perspectives of writing for HCPs to determine the most advantageous
methods in tailoring deliverable messaging.
Carrie Koenig, Vice President, Patient Experience & Communication
MEDSTAR HEALTH HOME CARE

11:45   SMALL GROUP DISCUSSION: INCREASING GLOBAL COLLABORATIONS IN LIGHT OF CULTURAL DIFFERENCES
As the global landscape of cultural and societal expectations continues to evolve with
time, being able to communicate effectively with global colleagues and audiences
becomes increasingly important in continuing to better medical communications. This
interactive discussion will break the audience into self-determined groups to discuss
strategies to implement for improved collaboration world-wide, in light of these cultural
and societal differences.
Dikran Toroser, Publications Lead
NOVARTIS (contract)
Nazan Artun, Associate Director, Scientific Communications and Training
TAKEDA

12:30   LUNCHEON FOR ALL SPEAKERS, SPONSORS & ATTENDEES

1:30   CASE STUDY: DEVELOPING A ROBUST AND BENEFICIAL OMNICHANNEL SYSTEM
● Critical elements necessary for compliant omnichannel systems
● Strategies for essential scaling needs based on focus markets
» Regional level
» Global level
● Preferential components according to target goals of system
Nikolas Karkanias, Vice President, Medical Engagement, Global Medical Affairs
TEVA PHARMACEUTICALS

2:15   CASE STUDY: MEDICAL COMMUNICATIONS REGARDING FDA’S SCIENTIFIC INFORMATION ON UNAPPROVED USES (SIUU)
• Discuss the main concepts of the FDAs draft guidance on SIUU
• Develop a process to compliantly create and disseminate SIUU materials
• Review SIUU material templates and real-world samples
• Reception of SIUU materials by field medical teams and HCPs
Vincent Dorsey, Director, Scientific Communications
ESPERION

3:00   COFFEE & NETWORKING BREAK

3:30   CASE STUDY: OPDP WARNING LETTERS ON REMAINING COMPLIANT WITH CFL GUIDANCE
Torrey Cope, Partner
SIDLEY AUSTIN LLP

4:15   Closing Remarks & Conference Conclusion